Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palifermin Treatment of Toxic Epidermal Necrolysis

NCT02037347 is registered in ClinicalTrials.gov with Brett King as lead sponsor.

NCT NCT02037347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02037347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palifermin Treatment of Toxic Epidermal Necrolysis
Lead sponsor
Brett King
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2010
Completion date
December 31, 2014
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stevens-johnson syndrome, toxic epidermal necrolysis